108 224

Cited 0 times in

Understanding CD4+ T cells in autoimmune bullous diseases

DC Field Value Language
dc.contributor.author김종훈-
dc.date.accessioned2023-07-12T02:48:04Z-
dc.date.available2023-07-12T02:48:04Z-
dc.date.issued2023-04-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/195401-
dc.description.abstractAutoimmune bullous diseases (AIBDs) are a group of life-threatening blisteri\ng diseases caused by autoantibodies that target proteins in the skin and mucosa. Autoantibodies are the most important mediator in the pathogenesis of AIBDs, and various immune mechanisms contribute to the production of these pathogenic autoantibodies. Recently, significant progress has been made in understanding how CD4(+) T cells drive autoantibody production in these diseases. Here, we review the critical role of CD4(+) T cells in the production of pathogenic autoantibodies for the initiation and perpetuation of humoral response in AIBDs. To gain an in-depth understanding of CD4(+) T-cell pathogenicity, antigen specificity, and mechanisms of immune tolerance, this review covers comprehensive mouse and human studies of pemphigus and bullous pemphigoid. Further exploration of pathogenic CD4(+) T cells will potentially provide immune targets for improved treatment of AIBDs.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherFrontiers Research Foundation-
dc.relation.isPartOfFRONTIERS IN IMMUNOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAnimals-
dc.subject.MESHAutoantibodies-
dc.subject.MESHAutoimmune Diseases*-
dc.subject.MESHCD4-Positive T-Lymphocytes / pathology-
dc.subject.MESHHumans-
dc.subject.MESHMice-
dc.subject.MESHSkin Diseases, Vesiculobullous*-
dc.subject.MESHT-Lymphocytes / pathology-
dc.titleUnderstanding CD4+ T cells in autoimmune bullous diseases-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Dermatology (피부과학교실)-
dc.contributor.googleauthorA Yeong Lee-
dc.contributor.googleauthorTaehee Kim-
dc.contributor.googleauthorJong Hoon Kim-
dc.identifier.doi10.3389/fimmu.2023.1161927-
dc.contributor.localIdA05233-
dc.relation.journalcodeJ03075-
dc.identifier.eissn1664-3224-
dc.identifier.pmid37138879-
dc.subject.keywordCD4 T cells-
dc.subject.keywordautoimmune bullous disease-
dc.subject.keywordbullous pemphigoid-
dc.subject.keywordpathogenicity-
dc.subject.keywordpemphigus-
dc.contributor.alternativeNameKim, Jong Hoon-
dc.contributor.affiliatedAuthor김종훈-
dc.citation.volume14-
dc.citation.startPage1161927-
dc.identifier.bibliographicCitationFRONTIERS IN IMMUNOLOGY, Vol.14 : 1161927, 2023-04-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Dermatology (피부과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.